Mark Shilkrut Selected Research

Mark Shilkrut Research Topics

Disease

8	Neoplasms (Cancer) 01/2021 - 02/2010
6	Melanoma (Melanoma, Malignant) 12/2018 - 02/2016
6	Prostatic Neoplasms (Prostate Cancer) 04/2016 - 01/2012
4	Neoplasm Metastasis (Metastasis) 12/2018 - 07/2013
2	Disease Progression 01/2021 - 01/2013
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 01/2018
2	AIDS-Related Complex (ARC) 10/2005 - 06/2002
2	Hypoxia (Hypoxemia) 10/2003 - 06/2002
1	Fatigue 01/2021
1	Neuroendocrine Carcinoma 01/2021
1	Nausea 01/2021
1	Liver Diseases (Liver Disease) 01/2018
1	Drug-Related Side Effects and Adverse Reactions 02/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2014
1	Paraganglioma (Paragangliomas) 02/2010
1	Pheochromocytoma 02/2010
1	Heart Failure 11/2007
1	Hypertrophy 10/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2003
1	Heart Diseases (Heart Disease) 06/2002
1	Ischemia 06/2002

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2002
2	talimogene laherparepvecIBA 12/2016 - 12/2016
2	AndrogensIBA 07/2013 - 02/2013
2	Prostate-Specific Antigen (Semenogelase)IBA 07/2013 - 02/2013
2	fas Receptor (CD95 Antigen)IBA 10/2005 - 06/2002
1	Alanine (L-Alanine)FDA Link 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	spartalizumabIBA 01/2021
1	trametinibIBA 12/2018
1	dabrafenibIBA 12/2018
1	Floxuridine (FUdR)FDA LinkGeneric 01/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018
1	Leucovorin (Folinic Acid)FDA Link 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2016
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 02/2016
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2015
1	Oxidoreductases (Dehydrogenase)IBA 05/2014
1	Gemcitabine FDA Link 05/2014
1	Cyclin D1IBA 01/2013
1	Androgen Receptors (Androgen Receptor)IBA 01/2013
1	CyclinsIBA 01/2013
1	Iodine-131IBA 02/2010
1	Hormones (Hormone)IBA 02/2010
1	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 10/2005
1	Inositol (Myoinositol)IBA 10/2005
1	1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dioneIBA 10/2005
1	Type C PhospholipasesIBA 10/2005
1	Atrial Natriuretic Factor (ANF)IBA 10/2005
1	Inositol 1,4,5-TrisphosphateIBA 10/2005
1	Connexin 43 (Connexin43)IBA 10/2005
1	Glycogen Synthase Kinase 3 betaIBA 10/2005
1	GenisteinIBA 10/2005
1	xestospongin CIBA 10/2005
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 10/2005
1	Messenger RNA (mRNA)IBA 10/2005
1	Apoptosis Regulatory ProteinsIBA 10/2003
1	Phosphotransferases (Kinase)IBA 10/2003
1	Tyrosine (L-Tyrosine)FDA Link 10/2003
1	Hemoglobins (Hemoglobin)IBA 06/2003

Therapy/Procedure

7	Therapeutics 01/2018 - 02/2010
5	Radiotherapy 01/2018 - 02/2013
3	Immunotherapy 01/2018 - 12/2016
2	Chemoradiotherapy 01/2018 - 05/2014
1	Length of Stay 02/2016
1	Drug Therapy (Chemotherapy) 05/2014
1	Prostatectomy (Retropubic Prostatectomy) 07/2013
1	Brachytherapy 02/2013
1	Cell Transplantation 11/2007
1	Transplantation 11/2007